Advertisement

Picture EBD Group Partnering Events Spring 2018 CBPF18 BES18 BEE18 600x060px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 2443 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
InflaRx–Leerink: investor conference, 201802 supply service InflaRx presents at Leerink Partners Global Healthcare Conference 2018 2018-02-14
4SC–Life Sciences Partners: investor conference, 201802 supply service 4SC AG presents at BioCapital Europe 2018 2018-02-06
Intelligent Pharma–Mind the Byte: investment, 201801 acquisition €na 100% of Intelligent Pharma by Mind the Byte 2018-01-11
Mind the Byte–SEVERAL: investment, 201801– financing round €3m (1/3 of company) to finance acquisition of Intelligent Pharma PLANNED 2018-01-11
Structural Genomics Consortium–Enamine: chemical compound libraries, 201801– supply new generation of Diamond-SGC-iNEXT (DSI) Poised Library 2018-01-10
BeiGene–Boehringer: biopharmaceuticals, 201801– supply manufacturing of tislelizumab by Boehringer in Shanghai 2018-01-09
BioNTech–Scancell: cancer immunotherapy, 201801– collab research using Moditope platform w excl license option for BioNTech 2018-01-09
Thermo Fisher–JPMorgan Chase: investor conference, 201801 supply service Thermo Fisher presents at JP Morgan Healthcare Conference 2018 2018-01-09
Bruker Corp–JPMorgan Chase: investor conference, 201801 supply service Bruker presents at JP Morgan Healthcare Conference 2018 2018-01-08
CureVac–JPMorgan Chase: investor conference, 201801 supply service CureVac presents at JP Morgan Healthcare Conference 2018 2018-01-08
General Electric–Roche: diagnostics, 201801– collab developm integrated digital + IVD + in vivo diagnostics platform for oncology + critical care 2018-01-08
Indivumed–EU (govt): credit, 201801– EIB/EFSI grant €40m to create Global Cancer Database Solution 2018-01-08
InflaRx–JPMorgan Chase: investor conference, 201801 supply service InflaRx presents at JP Morgan Healthcare Conference 2018 2018-01-08
TiGenix–Takeda: investment, 201801– aquisition public cash takeover offer €520m for remaining 95.8% for €1.78/share ANNOUNCED 2018-01-05
BioNTech–Fidelity: investment, 201801 financing round Series A totalling $270m incl new + co-investor Fidelity Management & Research 2018-01-04
BioNTech–Invus Group: investment, 201801 financing round Series A totalling $270m incl new + co-investor Invus 2018-01-04
BioNTech–Janus Henderson: investment, 201801 financing round Series A totalling $270m incl new + co-investor Janus Henderson Investors 2018-01-04
BioNTech–Redmile Group: investment, 201801 financing round Series A totalling $270m incl new + lead investor Redmile Group LLC 2018-01-04
BioNTech–SEVERAL: investment, 201801 financing round Series A $270m led by new investor Redmile Group LLC 2018-01-04
BioNTech–Strüngmann Group: investment, 201801 financing round Series A totalling $270m incl returning co-investor Strüngmann Family Office 2018-01-04
CureVac–Arcturus Therapeutics: mRNA therapeutics, 201801– strategic collab for lipid-mediated mRNA drugs using RNAoptimizer + LUNAR system 2018-01-04
CureVac–BMC Communications: public relations, 201801 service existent by BMC 2018-01-04
Enterome–BPCE: investment, 201801 financing round Series D totalling €32m incl existent investor Seventure + Health for Life Capital 2018-01-04
Enterome–Lundbeck: investment, 201801 financing round Series D totalling €32m incl existent investor LundbeckFonden Ventures 2018-01-04
Enterome–Nestlé: investment, 201801 financing round Series D totalling €32m incl existent investor Nestlé Health Science 2018-01-04
Enterome–SEVERAL: investment, 201801 financing round Series D €32m incl Seventure + Health for Life Capital + Lundbeck Fonden + Omnes Capital et al 2018-01-04
Miracor–SEVERAL: investment, 201801 financing round Series D €25m incl equity + debt + cash advance grant from Walloon govt 2018-01-04
Rewind Therapeutics–Boehringer: investment, 201801 financing round Series A totalling €15.2m incl co-lead investor BIVF 2018-01-04
Rewind Therapeutics–Flanders (govt): investment, 201801 financing round Series A totalling €15.2m incl co-lead investor PMV 2018-01-04
Rewind Therapeutics–Merck (DE): investment, 201801 financing round Series A totalling €15.2m incl co-lead investor Merck Ventures 2018-01-04
Rewind Therapeutics–SEVERAL: investment, 201801 financing round Series A €15.2m led by BIVF + Merck Ventures + PMV 2018-01-04
Rewind Therapeutics–Univ Leuven: investment, 201801 financing round Series A totalling €15.2m incl co-investors KU Leuven CD3 + KU Leuven GFF 2018-01-04
Themis Bioscience–SEVERAL: investment, 201801 financing round Series C €10m led by new investor GHIF 2018-01-04
Themis Bioscience–Trophic Communications: public relations, 201801 service existent by Trophic 2018-01-04
BASF–Biocrates: investment, 201801 acquisition of Metanomics Health GmbH by Biocrates from BASF Plant Science GmbH 2018-01-03
Biocrates–BASF: investment, 201801 financing round incl BASF Plant Science GmbH + MIG Fonds + GA Asset Fund 2018-01-03
Biocrates–MIG Fonds: investment, 201801 financing round incl BASF Plant Science GmbH + MIG Fonds + GA Asset Fund 2018-01-03
Biocrates–SEVERAL: investment, 201801 financing round incl BASF Plant Science GmbH + MIG Fonds + GA Asset Fund 2018-01-03
Biocrates–Xolaris Service KVG: investment, 201801 financing round incl BASF Plant Science GmbH + MIG Fonds + GA Asset Fund 2018-01-03
CRISPR Therapeutics–SEVERAL: investment, 201801 public offering $113.75m of 5m+750k common shares at $22.75/share 2018-01-03
Indivior–Addex: ADX71441, 201801– license + collab agreem $5m upfront + $4m research funding + $330m milestones plus royalties 2018-01-03
Central BioHub–in.vent Diagnostica: in vitro diagnostics, 201801 collab existent 2018-01-02
Siemens–OTHER: investment, 2018H1 PLANNED listing of newSiemens Healthineers AG at Frankfurt Stock Exchange 2018-01-01
BioNTech–ICR: public relations, 201712 service existent by ICR Healthcare in US 2017-12-21
BioNTech–JPMorgan Chase: investor conference, 201801 supply service BioNTech presents at JP Morgan Healthcare Conference 2018 2017-12-21
Ignyta–Roche: investment, 201712– cash tender offer $1.7b for all outstanding shares at $27/share 2017-12-21
Boehringer–Autifony: CNS drugs, 201712– collab €25m upfront + up to total of €627.5m excl option to acquire KV3.1/3.2 positive modulators for BI 2017-12-18
Roche–Horizon Discovery: reference standards, 201712– collab developm + supply of FFPE reference standards for ICH-NTRK assays for Roche Dx 2017-12-18
Fast Track Diagnostics–Siemens: investment, 201712 acquisiton €na of FTD by Siemens Healthineers 2017-12-15
CRISPR Therapeutics–Guggenheim: investor conference, 201712 supply service 1-on-1 meetings at Guggenheim Annual Boston Healthcare Conference 2017-12-13
Evotec–TU Dresden: drug discovery, 201712– collab research €na small-molecule candidates for retinal diseases using iPSC technology with CRTD 2017-12-13
Flexion Therapeutics–GeneQuine: gene therapy, 201712 acquisition $2m upfront + $62.7m milestones + royalties ww rights to GQ-203 by Flexion 2017-12-13
NorthSea Therapeutics–BASF: icosabutate, 201712– license from Pronova BioPharma Norge AS 2017-12-12
NorthSea Therapeutics–SEVERAL: investment, 201712 financing round Series A €25m co-led by Forbion + BGV + incl Novo Seeds + New Science Ventures 2017-12-12
AbeXXa Biologics–Boehringer: investment, 201712 existent investment by BIVF 2017-12-11
Aelin Therapeutics–Boehringer: investment, 201712 financing round Series A totalling €27m incl investor BIVF 2017-12-11
Aelin Therapeutics–Flanders (govt): investment, 201712 financing round Series A totalling €27m incl investor PMV 2017-12-11
Aelin Therapeutics–Fund+: investment, 201712 financing round Series A totalling €27m incl investor Fund+ 2017-12-11
Aelin Therapeutics–Life Sciences Partners: investment, 201712 financing round Series A totalling €27m incl lead investor LSP 2017-12-11
Aelin Therapeutics–Novartis: investment, 201712 financing round Series A totalling €27m incl investor Novartis Venture Fund 2017-12-11
Aelin Therapeutics–SEVERAL: investment, 201712 financing round Series A €27m from LSP + PMV + Novartis Venture Fund + BIVF + Fund+ 2017-12-11
Boehringer–AbeXXa Biologics: drug target research, 201712 collab existent to identify molecular protein targets for cancer 2017-12-11
Boehringer–Univ California: cancer vaccine, 201712 collab existent to develop vaccine technology platform with UCLA 2017-12-11
Hookipa Biotech–BioMedPartners: investment, 201712 financing round Series C totalling €50m incl returning investor BioMedPartners 2017-12-11
Hookipa Biotech–Boehringer: investment, 201712 financing round Series C totalling €50m incl returning investor BIVF 2017-12-11
Hookipa Biotech–Forbion: investment, 201712 financing round Series C totalling €50m incl returning investor Forbion Capital Partners 2017-12-11
Hookipa Biotech–Gilead: investment, 201712 financing round Series C totalling €50m incl new + strategic investor Gilead 2017-12-11
Hookipa Biotech–HBM: investment, 201712 financing round Series C totalling €50m incl new investor HBM Partners 2017-12-11
Hookipa Biotech–Hillhouse Capital: investment, 201712 financing round Series C totalling €50m incl new investor Hillhouse Capital 2017-12-11
Hookipa Biotech–OTHER: investment, 201712 financing round Series C totalling €50m incl undisclosed US public investment fund as new + lead investor 2017-12-11
Hookipa Biotech–SEVERAL: investment, 201712 financing round Series C €50m led by undisclosed US public investment fund 2017-12-11
Hookipa Biotech–Sirona Capital: investment, 201712 financing round Series C totalling €50m incl new investor Sirona Capital 2017-12-11
Hookipa Biotech–Sofinnova: investment, 201712 financing round Series C totalling €50m incl returning investor Sofinnova Partners 2017-12-11
Hookipa Biotech–Takeda: investment, 201712 financing round Series C totalling €50m incl returning investor Takeda Ventures 2017-12-11
thinXXS Microtechnology–Idex Corporation: investment, 201712 acquisition of thinXXS Microtechnology AG by Idex Corp 2017-12-11
PGS.Holland–bio.logis: genetic software, 201712– distribution of bio.logis GIMS in Benelux + Scandinavia + UK by PGS.Holland BV 2017-12-08
Cell Medica–Coulter Partners: recruitment services, 201712 supply service placement of Annalisa Jenkins as new Board Chair of Cell Medica 2017-12-07
Hepa Wash–Germany (govt): business development, 201712– supply service support in US with German Accelerator Life Sciences programme 2017-12-07
Charles River–ERS Genomics: CRISPR technology, 201712– license €na ww non-excl for CRISPR-Cas9 technology to generate modified cell lines 2017-12-06
CRISPR Therapeutics–Citigroup: investor conference, 201712 supply service 1-on-1 meetings at Citi Global Healthcare Conference NY 2017-12-06
Evotec–Berenberg: investor conference, 201712 supply service Evotec presents at Berenberg European Conference in Surrey 2017-12-06
Horizon Discovery–ERS Genomics: CRISPR technology, 201712– license ww non-excl expansion 2017-12-05
Novartis–Medigene: Veregen, 201712– acquisition €na of US rights to Veregen by Fougera Pharmaceuticals Inc 2017-12-05
Probiodrug–Crossbeta Biosciences: biomarker research, 201712– collab extension developm Alzheimer biomarker to support Probiodrug’s clinical program 2017-12-05
Probiodrug–MC Services: public relations, 201712 service existent by MC Services 2017-12-05
Probiodrug–Optimum Strategic Communications: public relations, 201712 service existent by Optimum 2017-12-05
Probiodrug–Trout Group: public relations, 201712 service existent by The Trout Group 2017-12-05
Arrowhead–Silence Therapeutics: investment, 201712 DIVESTMENT 2.036m common shares for $7.5m w realised profit of $4.1m 2017-12-04
Evotec–Ncardia: drug discovery technology, 201712– license ww non-excl €na to access iPSC-derived disease models of Ncardia 2017-12-04
JnJ–Idorsia: aprocitentan, 201712– collab developm + license ww commerc for Janssen $230m upfront + royalties 20–35% 2017-12-04
Roche–Confo Therapeutics: drug discovery services, 201712–202005 collab up to €87.5m plus milestones r+d + commerc small molecule GPCR agonists 2017-12-01
CRISPR Therapeutics–Barclays: investor conference, 201711 supply service CRISPR Tx presents at Barclays Gene Editing & Gene Therapy Summit 2017-11-30
CRISPR Therapeutics–Evercore: investor conference, 201711 supply service CRISPR Tx at Evercore ISI Biopharma Catalys / Deep Dive Conference 2017-11-30
I-Mab–MorphoSys: antibody cancer drug, 201711– license excl Greater China for MOR202 with $20m upfront + $100m milestones + tiered 2-digit royalties 2017-11-30
CRISPR Therapeutics–Piper Jaffray: investor conference, 201711 supply service CRISPR Therapeutics at Piper Jaffray Healthcare Conference 2017 2017-11-29
Abivax–Deutsche Börse: investor conference, 201711 supply service Abivax presents at Deutsches Eigenkapitalforum 2017 2017-11-28
Enyo Pharma–Charles River: drug discovery services, –201711 collab drug target identification of EYP002 using CCMS technology 2017-11-28
Bitkom–Bayer: digital economy, 201711 Bayer is member of Bitkom w particular focus on digital health + digital farming 2017-11-27
Boehringer–BioMed X: pharma research, 201711– collab new BioMed X research group in bacterial modulation of innate immunity 2017-11-27
Evotec–Deutsche Börse: investor conference, 201711 supply service Evotec AG presents at Deutsches Eigenkapitalforum 2017 2017-11-27
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25  next pagenext page



Advertisement

Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px

To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to info@iito.de and simply fill the subject line with the word »LSG newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x80px

» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group BIO-Europe Spring 2018 BES Amsterdam March 120x180px Picture EBD Group ChinaBio Partnering Forum 2018 Suzhou CBPF April 120x180px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture EBD Group Partnering Events Spring 2018 CBPF18 BES18 120x180px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group ChinaBio Partnering Forum 2018 Suzhou CBPF April 120x180px Picture EBD Group BIO-Europe Spring 2018 BES Amsterdam March 120x180px